-
What is the S&P 500?
The S&P 500 is one of the world’s most popular stock market indices and has almost tripled in value over the last decade. But what is the S&P 500, and which companies does it contain?
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
Opinion -
Best investing apps
Looking for an easy-to-use app to help you start investing, keep track of your portfolio or make trades on the go? We round up the best investing apps
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
-
Trump’s trade war: tariff exemptions widened for Canada and Mexico
Donald Trump has backtracked on several of the tariffs imposed on 4 March, granting broad exemptions to Canada and Mexico. What does it mean for markets and the economy?
-
Why now is the time to look again at private equity
Listed private equity investment trusts have faced multiple challenges despite a history of strong long term performance. But with the macroeconomic outlook now improving and individual funds such as HVPE taking decisive action, the sector may have reached a turning point
SPONSORED -
Halifax: House prices dip in February but will continue to rise
House prices dipped by 0.1% in February as the window to beat stamp duty changes narrowed, but a supply-demand imbalance could push prices higher this year overall
-
MoneyWeek exclusive: The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
Interview -
Vertex Pharmaceuticals is a rare opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
